S H L Telemedicine Ltd (SW:SHLTN) — Market Cap & Net Worth
Market Cap & Net Worth: S H L Telemedicine Ltd (SHLTN)
S H L Telemedicine Ltd (SW:SHLTN) has a market capitalization of $40.21 Million (CHF31.80 Million) as of May 2, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #22678 globally and #201 in its home market, demonstrating a 3.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying S H L Telemedicine Ltd's stock price CHF1.09 by its total outstanding shares 37058574 (37.06 Million). Analyse cash efficiency ratio of S H L Telemedicine Ltd to see how efficiently the company converts income to cash.
S H L Telemedicine Ltd Market Cap History: 2015 to 2026
S H L Telemedicine Ltd's market capitalization history from 2015 to 2026. Data shows change from $250.48 Million to $51.07 Million (-17.54% CAGR).
S H L Telemedicine Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how S H L Telemedicine Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.15x
S H L Telemedicine Ltd's market cap is 2.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $250.48 Million | $34.58 Million | -$16.64 Million | 7.24x | N/A |
| 2016 | $271.06 Million | $40.55 Million | -$11.10 Million | 6.68x | N/A |
| 2017 | $249.69 Million | $37.38 Million | $2.41 Million | 6.68x | 103.69x |
| 2018 | $241.38 Million | $48.86 Million | $10.14 Million | 4.94x | 23.80x |
| 2019 | $255.34 Million | $41.88 Million | $5.70 Million | 6.10x | 44.84x |
| 2020 | $557.54 Million | $40.16 Million | $278.00K | 13.88x | 2005.54x |
| 2021 | $894.87 Million | $49.58 Million | -$14.11 Million | 18.05x | N/A |
| 2022 | $693.41 Million | $59.00 Million | -$76.00K | 11.75x | N/A |
| 2023 | $325.62 Million | $57.08 Million | -$7.06 Million | 5.71x | N/A |
| 2024 | $121.82 Million | $56.78 Million | -$28.09 Million | 2.15x | N/A |
Competitor Companies of SHLTN by Market Capitalization
Companies near S H L Telemedicine Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to S H L Telemedicine Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #926 globally with a market cap of $28.21 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #2225 globally with a market cap of $10.06 Billion USD ( AU$14.22 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2339 globally with a market cap of $9.34 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2447 globally with a market cap of $8.82 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #926 | Veeva Systems Inc Class A | NYSE:VEEV | $28.21 Billion | $171.60 |
| #2225 | Pro Medicus Ltd | AU:PME | $10.06 Billion | AU$136.16 |
| #2339 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.34 Billion | $55.00 |
| #2447 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $8.82 Billion | $52.58 |
S H L Telemedicine Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, S H L Telemedicine Ltd's market cap moved from $250.48 Million to $ 51.07 Million, with a yearly change of -17.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF51.07 Million | -7.63% |
| 2025 | CHF55.29 Million | -54.62% |
| 2024 | CHF121.82 Million | -62.59% |
| 2023 | CHF325.62 Million | -53.04% |
| 2022 | CHF693.41 Million | -22.51% |
| 2021 | CHF894.87 Million | +60.50% |
| 2020 | CHF557.54 Million | +118.35% |
| 2019 | CHF255.34 Million | +5.79% |
| 2018 | CHF241.38 Million | -3.33% |
| 2017 | CHF249.69 Million | -7.88% |
| 2016 | CHF271.06 Million | +8.22% |
| 2015 | CHF250.48 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of S H L Telemedicine Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.21 Million USD |
| MoneyControl | $40.21 Million USD |
| MarketWatch | $40.21 Million USD |
| marketcap.company | $40.21 Million USD |
| Reuters | $40.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About S H L Telemedicine Ltd
SHL Telemedicine Ltd., together with its subsidiaries, provides telemedicine services in Israel, Europe, and internationally. The company offers SmartHeart platform, a 12-lead electrocardiogram (ECG) that enables a full, hospital-quality ECG to be performed by a lay-person without the assistance of a healthcare professional. It also provides preventative healthcare, including annual medical check… Read more